MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
168.32%
Quick Ratio
168.32%
Cash Ratio
166.69%
Debt to Asset Ratio
59.41%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Other current assets
Liabilities Breakdown
Additional paid in capital
Accumulated deficit
Employee compensation and benefi...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
22,160
25,130
31,634
35,442
Other current assets
216
268
75
145
Total current assets
22,376
25,398
31,709
35,587
Total assets
22,376
25,398
31,709
35,587
Accounts payable
5,184
4,695
6,274
6,439
Payable offering costs
-
-
-
75
Deferred fundraising receipts
1,388
-
-
-
Accrued liabilities
92
36
115
65
Employee compensation and benefits
6,630
6,447
6,907
4,998
Total current liabilities
13,294
11,178
13,296
11,577
Total liabilities
13,294
11,178
13,296
11,577
Additional paid in capital
121,839
119,957
118,100
116,383
Accumulated deficit
-112,757
-105,737
-99,687
-92,373
Total shareholders' equity
9,082
14,220
18,413
24,010
Total liabilities and shareholders' equity
22,376
25,398
31,709
35,587
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$22,160K
(-17.29%↓ Y/Y)
Other current assets
$216K
(0.93%↑ Y/Y)
Total current assets
$22,376K
(-17.15%↓ Y/Y)
Total assets
$22,376K
(-17.15%↓ Y/Y)
Total liabilities and
shareholders' equity
$22,376K
(-17.15%↓ Y/Y)
Total liabilities
$13,294K
(31.17%↑ Y/Y)
Total shareholders'
equity
$9,082K
(-46.17%↓ Y/Y)
Accumulated deficit
-$112,757K
(-32.79%↓ Y/Y)
Total current
liabilities
$13,294K
(31.17%↑ Y/Y)
Additional paid in capital
$121,839K
(19.70%↑ Y/Y)
Employee compensation
and benefits
$6,630K
(30.49%↑ Y/Y)
Accounts payable
$5,184K
(4.16%↑ Y/Y)
Deferred fundraising
receipts
$1,388K
Accrued liabilities
$92K
(4500.00%↑ Y/Y)
Buy us a coffee
Nuvectis Pharma, Inc. (NVCT)
Nuvectis Pharma, Inc. (NVCT)